NCT07468136 2026-04-13Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade GliomasMayo ClinicPhase 1/2 Not yet recruiting33 enrolled
NCT00095940 2014-05-23Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System TumorsNational Cancer Institute (NCI)Phase 1/2 Completed52 enrolled 17 charts